Navigation Links
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
Date:10/26/2008

nts regarding the performance, demand and outlook for our products, including our Trofile and our projected revenues. These forward-looking statements are subject to risks and uncertainties and other factors, which may cause actual results to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These risks and uncertainties include, but are not limited to: risks and uncertainties relating to the performance and acceptance of our products; the growth in revenues; the size, timing and success or failure of any clinical trials for CCR5 inhibitors, entry inhibitors or integrase inhibitors; our ability to establish reliable, high-volume operations at commercially reasonable costs; expected reliance on a few customers for the majority of our revenues; the annual renewal of certain customer agreements; actual market acceptance of our products and adoption of our technological approach and products by pharmaceutical and biotechnology companies; our estimate of the size of our markets; our estimates of the levels of demand for our products; the impact of competition; the timing and ultimate size of pharmaceutical company clinical trials; whether payers will authorize reimbursement for our products and services and the amount of such reimbursement that may be allowed; whether the FDA or any other agency will decide to further regulate our products or services, including Trofile; whether existing levels of reimbursement will be reviewed and reduced by third party payers, including Medicare; whether the draft guidance on Multivariate Index Assays issued by the FDA will be subsequently determined to apply to our current or planned products; whether we will encounter problems or delays in automating our processes; the ultimate validity and enforceability of our patent applications and patents; the possible infringement of the intellectual property of others; whether licenses to third party technology will be available;
'/>"/>
SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
4. RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial
5. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
6. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
7. New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
8. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
9. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
10. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
11. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... methamphetamine offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... NEW YORK , Aug. 20, ... a new market research report is ... The Market for Hospital-Acquired Infection Control ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html ... and healthcare-associated infections (HAIs), demand has ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
... GenVec, Inc. (Nasdaq: GNVC ) announced today that ... Research (SBIR) grant from the National Cancer Institute (NCI) of ... of a new approach to treating metastatic cancer. Under this ... that the delivery of a specific gene will stimulate an ...
... , PITTSBURGH, Sept. 30 ThermalTherapeutic Systems, Inc., ... standardize hyperthermic perfusion announced today the completion of ... After receiving initial start-up funding by the Pittsburgh ... financing which included follow-on investments by the Pittsburgh ...
Cached Medicine Technology:GenVec Receives National Cancer Institute Grant to Expand Cancer Program 2ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures 2
(Date:8/21/2014)... (PRWEB) August 21, 2014 Living in ... the atmosphere that comes along with it. A quality ... sure that such amenities are available. , ... in Fayetteville, Georgia and Community Association Management, LLC made ... American Parks Company to provide an additional amenity for ...
(Date:8/21/2014)... people, finding motivation to exercise is a challenge. Thankfully, there ... of Zombies, Run!one of more than 31,000 health and fitness ... number of apps that use games to increase physical activity. ... app makers looking to cash in to help people get ... remains to be seen. , "It,s just been assumed that ...
(Date:8/21/2014)... environmental source of fungal infections that have been sickening ... grows on trees. , The discovery is based on ... the summer gathering soil and tree samples from areas ... fungus named Cryptococcus gattii (CRIP-to-cock-us GAT-ee-eye). ... of species including C. gattii , causes life-threatening ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Being born at a ... type 2 diabetes, a new study suggests. The findings ... population that has a high prevalence of low birth weight, ... black women found that those with a low birth weight ... than those with a normal birth weight. The risk of ...
(Date:8/21/2014)... MD (PRWEB) August 21, 2014 A ... reported a 63% increase in disability associated with speech ... with a more than 15% increase in disability associated ... early intervention for rising numbers of children who are ... Association (ASHA). , On a broader level, ...
Breaking Medicine News(10 mins):Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3
... people surveyed know to call 911 when one happens, CDC says ... are not aware of all the warning signs of a heart ... is suspected is not as high as it could be, a ... , The survey results, released Thursday in the CDC,s ...
... Ky. (Feb. 21, 2008) − It,s the leading cause ... the thickening of arterial walls, restricting blood flow like ... still largely a puzzle to scientists working to put ... complete picture of health for millions of patients who ...
... available in Spanish . , There are ... health. However, they are vitally important for patients well-being: they ... at the Department of Social Anthropology of the ... Briones Gmez, shows that Spanish hospitals are not adapted to ...
... Inc. (NYSE: MYL ),announced today that it has ... for the quarter and nine months ended Dec. 31, ... from 10:30 a.m. as previously,announced., The dial-in number ... callers. A replay, available for approximately eight,days, will be ...
... cancer therapeutics company, today announced that it will shortly,commence ... Algeta filed its Investigational New Drug (IND) application for ... Drug,Administration (FDA) in December 2007. The statutory 30 day ... 30 days by agreement with the,company and the IND ...
... DEERFIELD, Ill., Feb. 21 American Imaging Management,(AIM), ... WLP ), and a,leading radiology benefit management and ... million consumers, has introduced an,enhanced Patient Safety Program ... imaging procedures, such as computed tomography,(CT) scans and ...
Cached Medicine News:Health News:Awareness of Heart Attack Signs Lags in U.S. 2Health News:Awareness of Heart Attack Signs Lags in U.S. 3Health News:Patients' relatives are ignored by the health system and suffer emotional stress 2Health News:Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA 2Health News:Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA 3Health News:American Imaging Management Launches Patient Safety Program to Increase Awareness of Radiation Dose Associated with Advanced Imaging Procedures 2Health News:American Imaging Management Launches Patient Safety Program to Increase Awareness of Radiation Dose Associated with Advanced Imaging Procedures 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: